Description
enfermedad de Addison sin tratamiento
PRINCIPIO ACTIVO: IRBESARTAN
Forma farmacéutica: Polvo para suspensión intravesical
SUSTANCIA: PRIMOTESTON DEPOT INY
Enfermedad cardiaca isquémica establecida
GONAPEPTYL DEPOT 1 X 3.75MG PISA enfermedad de Addison sin tratamientoAcetato de triptorelina 3. 75 MG
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
